Cargando…
Novel RNA aptamers targeting gastrointestinal cancer biomarkers CEA, CA50 and CA72-4 with superior affinity and specificity
Gastric cancer is the third most common cause of death from cancer in the world and it remains difficult to cure in Western countries, primarily because most patients present with advanced disease. Currently, CEA, CA50 and CA72-4 are commonly used as tumor markers for gastric cancer by immunoassays....
Autores principales: | Pan, Qing, Law, Carmen O. K., Yung, Mingo M. H., Han, K. C., Pon, Yuen Lam, Lau, Terrence Chi Kong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179186/ https://www.ncbi.nlm.nih.gov/pubmed/30303958 http://dx.doi.org/10.1371/journal.pone.0198980 |
Ejemplares similares
-
Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy
por: Sun, Zhipeng, et al.
Publicado: (2014) -
Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9.
por: Nilsson, O., et al.
Publicado: (1992) -
Clinical Significance and Prognostic Value of CA72-4 Compared with CEA and CA19-9 in Patients with Gastric Cancer
por: Ychou, M., et al.
Publicado: (2000) -
Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer
por: Liang, Yao, et al.
Publicado: (2016) -
CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA.
por: Haglund, C., et al.
Publicado: (1994)